The Revenue Integrity Symposium is truly one of the first and most comprehensive revenue integrity programs available in the country. Anyone with responsibilities in any revenue cycle related function or process, should consider attending.
CMS’ 2019 OPPS proposed rule, released in late July, continues the agency’s efforts to enforce site-neutral payments and reduce drug payments by introducing policies to reduce reimbursement for hospital outpatient clinic visits at off-campus, provider-based departments.
The Revenue Integrity Symposium (RIS) is such an important event to anyone in the revenue integrity profession because while there are many conferences that touch upon aspects of revenue integrity, RIS is the only one entirely dedicated to that topic.
Implementing a denial avoidance initiative can help facilities and health systems realize lost revenue, achieve cost savings, and improve an organization’s financial performance.
NAHRI’s 2018 Revenue Integrity Symposium is fast approaching, and I am very much looking forward to what’s in store—both at the conference and in the Phoenix area where I reside. Phoenix is truly a beautiful area and the Revenue Integrity Symposium allows you to take in all it has to offer during one of the most beautiful times of year.
Along with quality measure removals in the 2018 OPPS and MPFS final rules, CMS has continued to propose additional removals in the 2019 proposed rules. In addition, the agency is proposing to add to its ability to remove quality measures in the future.
In the 2019 OPPS proposed rule, CMS does not introduce a new skin substitute payment policy but is seeking comment on potential changes for future rulemaking.
